TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice
- 1 July 2011
- journal article
- research article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 111 (1), 200-205
- https://doi.org/10.1152/japplphysiol.00248.2011
Abstract
Previously, we demonstrated functional substitution of dystrophin by TAT-μUtrophin (TAT-μUtr) in dystrophin-deficient mdx mice. Herein, we addressed whether TAT-μUtr could improve the phenotype of dystrophin and utrophin double-knockout ( mdx:utr−/−) mice. Specifically, we quantitatively compared survival and quality of life assessments in mdx:utr−/− mice receiving TAT-μUtr protein administration against placebo-treated mdx:utr−/− mice (PBS). Additionally, skeletal muscles from TAT-μUtr and PBS mice were tested in vivo and ex vivo for strength and susceptibility to eccentric contraction-induced injury. We found the TAT-μUtr treatment extended life span 45% compared with mice administered PBS. This was attributed to significantly increased food consumption (3.1 vs. 1.8 g/24 h) due to improved ability to search for food as daily cage activities were greater in TAT-μUtr mice (e.g., 364 vs. 201 m ambulation/24 h). The extensor digitorum longus muscles of TAT-μUtr-treated double-knockout mice also displayed increased force-generating capacity ex vivo (8.3 vs. 6.4 N/cm2) and decreased susceptibility to injury ex vivo and in vivo. These data indicate that the functional benefits of TAT-μUtr replacement treatment extend to the mdx:utr−/− double-knockout mouse and support its development as a therapy to mitigate muscle weakness in patients with Duchenne muscular dystrophy.Keywords
This publication has 36 references indexed in Scilit:
- Marginal Level Dystrophin Expression Improves Clinical Outcome in a Strain of Dystrophin/Utrophin Double Knockout MicePLOS ONE, 2010
- Progressive resistance voluntary wheel running in the mdx mouseMuscle & Nerve, 2010
- Effects of prednisolone on skeletal muscle contractility in mdx miceMuscle & Nerve, 2009
- Functional Substitution by TAT-Utrophin in Dystrophin-Deficient MicePLoS Medicine, 2009
- Sarcospan reduces dystrophic pathology: stabilization of the utrophin–glycoprotein complexThe Journal of cell biology, 2008
- Adaptive and nonadaptive responses to voluntary wheel running by mdx miceMuscle & Nerve, 2008
- Microutrophin Delivery Through rAAV6 Increases Lifespan and Improves Muscle Function in Dystrophic Dystrophin/Utrophin-deficient MiceMolecular Therapy, 2008
- Transduction of Full-length Dystrophin to Multiple Skeletal Muscles Improves Motor Performance and Life Span in Utrophin/Dystrophin Double Knockout MiceMolecular Therapy, 2008
- Molecular and cellular contractile dysfunction of dystrophic muscle from young miceMuscle & Nerve, 2006
- Comparison of force and stiffness in normal and dystrophic mouse musclesMuscle & Nerve, 1988